182 related articles for article (PubMed ID: 23161175)
21. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
[TBL] [Abstract][Full Text] [Related]
22. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity.
Morsy H; Kamp S; Thrane L; Behrendt N; Saunder B; Zayan H; Elmagid EA; Jemec GB
Arch Dermatol Res; 2010 Mar; 302(2):105-11. PubMed ID: 19894055
[TBL] [Abstract][Full Text] [Related]
23. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease.
Deeva I; Mariani S; De Luca C; Pacifico V; Leoni L; Raskovic D; Kharaeva Z; Korkina L; Pastore S
Cytokine; 2010 Feb; 49(2):163-70. PubMed ID: 19879157
[TBL] [Abstract][Full Text] [Related]
24. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
25. Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)--do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)?
Buske-Kirschbaum A; Ebrecht M; Kern S; Hellhammer DH
Psychoneuroendocrinology; 2006 May; 31(4):439-46. PubMed ID: 16359823
[TBL] [Abstract][Full Text] [Related]
26. Serotonergic drugs--a possible role in the treatment of psoriasis?
Thorslund K; Nordlind K
Drug News Perspect; 2007 Oct; 20(8):521-5. PubMed ID: 18080039
[TBL] [Abstract][Full Text] [Related]
27. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
28. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
29. Vulvar pruritus and burning sensation in women with psoriasis.
Zamirska A; Reich A; Berny-Moreno J; Salomon J; Szepietowski JC
Acta Derm Venereol; 2008; 88(2):132-5. PubMed ID: 18311439
[TBL] [Abstract][Full Text] [Related]
30. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients.
Kotrulja L; Tadinac M; Joki-Begi NA; Gregurek R
Acta Derm Venereol; 2010 May; 90(3):251-6. PubMed ID: 20526541
[TBL] [Abstract][Full Text] [Related]
31. Local effects of TL01 phototherapy in psoriasis.
DeSilva B; McKenzie RC; Hunter JA; Norval M
Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):268-9. PubMed ID: 18811869
[TBL] [Abstract][Full Text] [Related]
32. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
Berth-Jones J; Thompson J; Papp K;
Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
[TBL] [Abstract][Full Text] [Related]
33. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
Williamson L; Dalbeth N; Dockerty JL; Gee BC; Weatherall R; Wordsworth BP
Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998
[TBL] [Abstract][Full Text] [Related]
34. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
[TBL] [Abstract][Full Text] [Related]
36. Physical and psychologic measures are necessary to assess overall psoriasis severity.
Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus.
Shah B; Ashok L; Sujatha GP
Indian J Dent Res; 2009; 20(3):288-92. PubMed ID: 19884710
[TBL] [Abstract][Full Text] [Related]
38. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
[TBL] [Abstract][Full Text] [Related]
39. Quantitative evaluation of severity in psoriatic lesions using three-dimensional morphometry.
Park SY; Ha SH; Yu DS; Son SW; Kim DJ; Kim IH; Moon JS; Kim MK; Oh CH
Exp Dermatol; 2004 Apr; 13(4):223-8. PubMed ID: 15086337
[TBL] [Abstract][Full Text] [Related]
40. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
